Antengene Corporation Ltd.

05/14/2021 | Press release | Distributed by Public on 05/14/2021 08:34

VOLUNTARY ANNOUNCEMENT NMPA APPROVAL OF IND APPLICATION FOR A PHASE IB/II CLINICAL TRIAL OF ELTANEXOR IN ADVANCED SOLID TUMORS